SIRIC ILIAD 2023-2027
Organized around a research-care continuum, ILIAD brings together medical, scientific, and technological expertise while combining different disciplines.
ILIAD relies on integrated, innovative, and multidisciplinary research to detect, treat, and ensure sustainable employment for high-risk patients. Centered around the care pathway, the research conducted by ILIAD teams also focuses on patients’ life paths, incorporating issues of social inequalities and employment retention in the face of illness.
The research programs are implemented on two selected tumors as demonstrators: multiple myeloma and breast cancer.

Predict and characterize high-risk patients.
Develop early detection of high-risk patients to tailor treatments and offer personalized therapies.

NEWS
The SIRIC ILIAD supports young researchers and the emergence of innovative projects
Save the date: ‘From biomarkers to innovative therapies in high-risk cancers’ symposium, May 27, 2025
A new cyclotron co-operated by GIP ARRONAX and Curium PET France
New Certification for CLIP²-ILIAD!
Public lecture: Breast cancer & work – October 10, 2024
